Here you can find press releases, news, prospectus, presentations and financial reports about Immunovia AB. Additionally, we have included information about the share, the owners, insider trading, calendar and financial situation.
If you have further questions, please contact our IR contact.
If you are interested to receive our press releases and reports, please click on “Subscribe”.
The Immunovia AB share is since 3 April 2018 traded on Nasdaq Stockholm. Immunovia has one class of shares. The Company has a registered share capital of SEK 865,902.95 allocated among 17,318,059 shares. The par value of the shares is SEK 0.05 per share.
Ticker on Nasdaq Stockholm: IMMNOV
The shares are registered by the Euroclear Sweden.
CEO summarizes year 2015 in this first shareholder newsletter.